Levobunolol Hydrochloride

CHEMBL1201177 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

327.8 g/mol

LogP

—

Phase

4

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

分子量

327.8000 g/mol

TPSA

58.60 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O.Cl

InChI

InChI=1S/C17H25NO3.ClH/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20;/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3;1H/t12-;/m0./s1

Molecular Formula

C17H26ClNO3

HBD / HBA

3 / 4

回転可能結合数

6

重原子数

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The hydrochloride salt form of levobunolol, a non-selective beta-blocker eye drop used to treat glaucoma. It is the standard pharmaceutical preparation of this ophthalmic medication.

Yes, Levobunolol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201177. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5284409. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Levobunolol Hydrochloride PillFYIで

構造

クイックデータ

分子式: C17H26ClNO3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.